Table 1 Characteristics of the study population.

From: Relation between characteristics of carotid atherosclerotic plaques and brain white matter hyperintensities in asymptomatic patients

Demographic characteristics

N = 67

Age, years

69 ± 8

Female, n(%)

29 (43)

Cardiovascular Risk Factors

Family history of CAD, n(%)

23 (34)

Family history of stroke, n(%)

8 (12)

Systemic arterial hypertension, n(%)

51 (76)

Resistant hypertension, n(%)

12 (18)

Hypercholesterolemia, n(%)

47 (70)

Type 2 diabetes mellitus, n(%)

16 (24)

Current smoker, n(%)

13 (20)

Previous smoker, n(%)

29 (43)

Body mass index (kg/cm2)

25 ± 4

Framingham risk score (%)

13 (6–20)

High cardiovascular risk n(%)

36 (54)

Cardiovascular History

Previous acute coronary syndrome, n(%)

7 (10)

Clinical Characteristics

Heart rate, bpm

73 (67–80)

Systolic blood pressure, mmHg

130 (125–145)

Diastolic blood pressure, mmHg

80 (70–80)

Laboratory Parameters

White blood cells, 109/L

7.4 ± 1.7

Haemoglobin, g/dL

14 (13–15)

Platelets, 109/L

205 (163–254)

Total cholesterol, mg/dL

175 (157–198)

LDL cholesterol, mg/dL

105 ± 33

HDL cholesterol, mg/dL

43 (38–50)

Triglyceridemia, mg/dL

129 (96–162)

Glycemia, mg/dL

99 (88–127)

Creatinine, mg/dL

0.85 (0.72–1.04)

eGFR, mL/min

72 (58–95)

Medical Therapy

ACE inhibitors/ARBs, n(%)

41 (61)

β-blockers, n(%)

27 (40)

Calcium antagonists, n(%)

18 (27)

Diuretics, n (%)

15 (22)

Others vasodilators, n(%)

4 (6)

Number of anti-hypertensive agents

1 (0–2)

Statins, n(%)

40 (60)

Antiplatelet agent, n(%)

41 (61)

  1. High cardiovascular risk score defined as Framingham risk score > 20%, and/or the presence of diabetes mellitus and/or manifest cardiovascular disease. CAD, coronary artery disease; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate; ACE, angiotensin converting enzyme; ARBs, Angiotensin Receptor Blockers.